Case | Age (yrs) | Pre-conceptional; Referral-week | Kidney disease | sCr mg/dL (EPI-GFR mL/min) | CKD stage | PtU (g/24 h) | Pt/Alb (g/dL) | HT | Therapy at referral | BMI |
---|---|---|---|---|---|---|---|---|---|---|
1 | 35 | pre; ICSI | Diab neph | 1.2 (59) | 3 | 2.5 | 5.9/2.8 | Yes | Insulin, doxazosine | 23.5 |
2 | 35 | pre; 8w | Diab neph | 1.6 (45) | 4 | 1.8 | 6.5/3.8 | No | Insulin | 22 |
3 | 28 | 7w | Sponge kidney | 3.2 (19) | 4 | 0.8 | 6.5/3.5 | No | EPO, Vit. D | 22 |
4 | 37 | pre; 6w | Diab neph | 1.2 (58) | 3 | 5.9 | 5.8/3.2 | No | Insulin | 22 |
5 | 32 | 6w | SLE | 0.7 (115) | 1 | 2.7 | 6.0/3.1 | Yes | Pred., ASA, omeprazole, a-MD | 24 |
6 | 35 | pre; 7w | Reflux | 3.2 (18) | 4 | 1.0 | 8.4/4.5 | Yes | Vit. D, b-blocker ASA | 19 |
7 | 29 | 9w | Diab neph | 1.5 (47) | 3 | 6.3 | 6.6/3.6 | Yes | Insulin, nifedipine | 20 |
8 | 38 | 17w | fibrillary GN | 0.6 (116) | 1 | 3.6 | 5.8/2.6 | No | None | 22 |
9 | 32 | 6w | Kidney graft | 1.2 (60) | 2 | 0.5 | 6.9/4.0 | No | Pred., CyA, ranitidine, ASA, | 24 |
10 | 20 | 5w | SLE | 0.6 (132) | 1 | 2.5 | 6.8/3.3 | No | Pred. | 21 |
11 | 37 | 7w | Kidney graft | 1.5 (44) | 3 | 0.8 | 7.0/3.9 | Yes | Pred., CyA, VitD, nifedipine, ASA EPO, ranitidine | 27 |
12 | 30 | 6w | IgA GN | 1.3 (55) | 3 | 0.7 | 6.9/4.1 | No | Levothyroxine | 18.9 |
13 | 28 | 10w | IgA GN | 1 (77) | 2 | 2 | 6.6/3.7 | No | None | 19.9 |
14 | 36 | pre; 5w | Diab neph | 1 (68) | 2 | 0.6 | 6.4/4.1 | Yes | Lansoprazole, levothyroxine, ASA, Niphedipine, insulin, | 21.5 |
15 | 35 | 7w | Diab neph | 1.2 (56) | 3 | 0.7 | 7.4/4.3 | No | Insulin | 18.2 |
16 | 40 | 24w | Diab neph | 0.9 (76) | 2 | 3.1 | 6.7/3.3 | Yes | Insulin, levothyroxine, Nifedipine | 24 |
17 | 36 | 20w | IgA GN | 1.1 (64) | 2 | 2.4 | 5.6/4.1 | No | None | 22.3 |
18 | 36 | pre; 7w | SLE | 2.9 (20) | 4 | 3.4 | 6.5/3.9 | Yes | Pred., levothyroxine, a-MD | 24.5 |
19 | 38 | 6w | FSGS | 0.6 (116) | 1 | 2.1 | 6.3/3.3 | No | CyA | 25 |
20 | 33 | pre; 8w | Kidney graft | 1.3 (52) | 3 | 0.2 | 7.2/3.9 | Yes | Pred, TAC | 30 |
21 | 31 | pre; 9w | Sponge kidney | 1.6 (43.3) | 3 | 0.3 | 6.5/4.0 | Yes | ASA, a-MD | 23.4 |
22 | 33 | pre; 7w | Reflux | 0.7 (110.4) | 1 | 0.8 | 6.0/3.7 | Yes | ASA, b-bloc | 21.8 |
23 | 38 | pre; 6w | Pyelonephritis | 1.2 (59) | 3 | 0.2 | 6.5/3.9 | Yes | a-MD | 19.7 |
24 | 26 | 5w | Single kidney, previous HUS | 1 (78) | 2 | 0.3 | 6.8/3.8 | Yes | ASA | 23.4 |
25 | 41 | pre; 7w | GN | 0.8 (86.6) | 2 | 0.8 | 7.2/3.8 | Yes | ASA | 33.6 |
26 | 32 | 6w | IgA GN | 1 (74.7) | 2 | 0.6 | 6.8 /3.9 | No | ASA | 24.9 |
27 | 36 | 18w | Diab neph | 0.7 (106.3) | 1 | 0.9 | 7.4/4.4 | Yes | ASA, a-MD, Insulin | 34 |
28 | 33 | 27w | LLAC | 0.4 (136.2) | 1 | 1.3 | 6.0/3.6 | Yes | a-MD | 29.7 |
29 | 33 | 14w | Unknown | 0.8 (105.6) | 1 | 2.2 | 5.7/3.0 | No | ASA | 24.8 |
30 | 32 | 30w | Unknown | 1.7 (39.6) | 3 | 0.1 | 6.2/3.6 | No | / | 26.7 |
31 | 31 | 8 w | Diab neph | 1.48 (47) | 3 | 0.1 | 6.78/4.68 | No | ASA, Insulin | 19.5 |
32 (twin) | 31 | 21w | Diab neph | 0.5 (128) | 1 | 5.4 | 5.5/2.8 | No | Insulin, levothyroxine | 17.9 |
33 (twin) | 37 | 12w | Unknown | 0.7 (112) | 1 | 0.8 | 7.1/3.5 | No | None | 31.4 |
34 (twin) | 39 | 11 w | Previous PNA | 0.57 (184.1) | 1 | 0.29 | 6.11/3.37 | No | ASA | 32.32 |
35 (termination) | 26 | 18w | MGN | 0.6 (126) | 1 | 5.5 | 5.1/2.3 | No | None | 19 |
36 (miscarriage) | 37 | 7w | Kidney graft | 1.7 (38) | 3 | 0.1 | 6.9/3.9 | Yes | Pred., TAC, EPO, ASA, omeprazole, Doxazosin, b-bloc | 25.1 |
Summary data all cases Median (min-max) | 34 (20–41) | 7 (5–30) | _ | sCr 1.05 (0.4–3.2) GFR-EPI 66.0 (18.0–184.1) | 2 (1–4) | 0.8 (0.1–6.3) | Pt 6.5 (5.1–8.4) Alb 3.75 (2.3–4.68) | 17/36 47.2 % | _ | 23.4 (17.9–34.0) |
Summary data Singletons Median (min-max) | 33 (20–41) | 7 (5–30) | _ | sCr 1.20 (0.4–3.2) GFR-EPI 60.0 (18.0–136.2) | 3 (1–4) | 0.9 (0.1–6.3) | Pt 6.5 (5.6–8.4) Alb 3.8 (2.6–4.68) | 16/31 51.6 % | _ | 23.4 (18.2–34.0) |